l General Information |
Product Name | Velpatasvir |
General description | Velpatasvir is a Hepatitis C Virus NS5A Inhibitor. |
Synonym | GS 5816; GS5816; KCU0C7RS7Z |
Purity | ≥98%(HPLC) | CAS Number | 1377049-84-7 |
Formula | C49H54N8O8 | Molecular Weight | 883.019 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White to pale yellow solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | ≥50mg/mL |
Water | N/A |
l Biological Information |
Biochem/Physiol Actions | Velpatasvir is a small molecule direct-acting antiviral used in the treatment of hepatitis C in combination with sofosbuvir. Velpatasvir prevents viral replication by inhibiting non-structural protein 5A (NS5A) [A19177]. At a dose 5 times the recommended dose, velpatasvir does not prolong QTc interval to any clinically relevant extent [FDA Label]. |
Application | Antiviral Agents |
l Packaging & Storage |
Packaging | 50mg; 250mg |
Storage temp. | 0-5℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
